Evidence map›Paper›PMID 39285269›Full record

ArticleCancer & metabolism2024

Metabolism of primary high-grade serous ovarian carcinoma (HGSOC) cells under limited glutamine or glucose availability.

Daniela Šimčíková, Dominik Gardáš, Tomáš Pelikán, Lukáš Moráň, Martin Hruda, Kateřina Hložková, Tiziana Pivetta, Michal Hendrych, Júlia Starková, Lukáš Rob and 2 more

Abstract read
In one paragraph

Article in Cancer & metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Cross-assay RNA modeling reveals cancer biomarkers.bioRxiv : the preprint server for biology · 2026
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daniela ŠimčíkováThird Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic.
Dominik GardášThird Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic.
Tomáš PelikánThird Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic.
Lukáš MoráňDepartment of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Martin HrudaThird Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic.
Kateřina HložkováDepartment of Pediatric Hematology and Oncology, Second Faculty of Medicine, CLIP - Childhood Leukaemia Investigation Prague, Charles University, Prague, Czech Republic.
Tiziana PivettaDepartment of Chemical and Geological Sciences, University of Cagliari, Monserrato, CA, Italy.
Michal HendrychFirst Department of Pathology, St. Anne's University Hospital, Brno, Czech Republic.
Júlia StarkováDepartment of Pediatric Hematology and Oncology, Second Faculty of Medicine, CLIP - Childhood Leukaemia Investigation Prague, Charles University, Prague, Czech Republic.
Lukáš RobThird Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic.
Petr VaňharaDepartment of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Petr HenebergThird Faculty of Medicine, Charles University, Ruská 87, Prague, CZ-100 00, Czech Republic. petr.heneberg@lf3.cuni.cz.

Funding

Agentura Pro Zdravotnický Výzkum České Republiky NU21-03-00539Univerzita Karlova v Praze 324421
6 · The paper itself

Abstract

backgroundHigh-grade serous ovarian carcinoma (HGSOC) is the most common and aggressive subtype of epithelial ovarian carcinoma. It is primarily diagnosed at stage III or IV when the 5-year survival rate ranges between 20% and 40%. Here, we aimed to validate the hypothesis, based on HGSOC cell lines, that proposed the existence of two distinct groups of HGSOC cells with high and low oxidative phosphorylation (OXPHOS) metabolism, respectively, which are associated with their responses to glucose and glutamine withdrawal.

methodsWe isolated and cultivated primary cancer cell cultures from HGSOC and nontransformed ovarian fibroblasts from the surrounding ovarium of 45 HGSOC patients. We tested the metabolic flexibility of the primary cells, particularly in response to glucose and glutamine depletion, analyzed and modulated endoplasmic reticulum stress, and searched for indices of the existence of previously reported groups of HGSOC cells with high and low OXPHOS metabolism.

resultsThe primary HGSOC cells did not form two groups with high and low OXPHOS that responded differently to glucose and glutamine availabilities in the cell culture medium. Instead, they exhibited a continuum of OXPHOS phenotypes. In most tumor cell isolates, the responses to glucose or glutamine withdrawal were mild and surprisingly correlated with those of nontransformed ovarian fibroblasts from the same patients. The growth of tumor-derived cells in the absence of glucose was positively correlated with the lipid trafficking regulator FABP4 and was negatively correlated with the expression levels of HK2 and HK1. The correlations between the expression of electron transport chain (ETC) proteins and the oxygen consumption rates or extracellular acidification rates were weak. ER stress markers were strongly expressed in all the analyzed tumors. ER stress was further potentiated by tunicamycin but not by the recently proposed ER stress inducers based on copper(II)-phenanthroline complexes. ER stress modulation increased autophagy in tumor cell isolates but not in nontransformed ovarian fibroblasts.

conclusionsAnalysis of the metabolism of primary HGSOC cells rejects the previously proposed hypothesis that there are distinct groups of HGSOC cells with high and low OXPHOS metabolism that respond differently to glutamine or glucose withdrawal and are characterized by ETC protein levels.

Indexed as

Epithelial ovarian carcinomaMetabolism reprogrammingOvarian fibroblastsOxidative phosphorylationPatient-derived cellsUnfolded protein response

Identifiers

PMID39285269
PMCPMC11403878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.